Finance

Lists
Why is 8CC up 4.04%?
Dive Deeper
8CC:FRA
Cocrystal Pharma Inc
€1.03
+4.04%
(+0.040) 1D
Sep 29, 8:01:34 AM GMT+2  ·   EUR
All symbols
SymbolPriceChange% Change
Generating top insights for 8CC...
Open
€1.03
High
€1.03
Low
€1.03
Mkt. cap
23.31M
Avg. vol.
0.00
Volume
0.00
52-wk high
€1.30
52-wk low
€0.69
No. of employees
10
Open
€1.03
High
€1.03
Low
€1.03
Mkt. cap
23.31M
Avg. vol.
0.00
Volume
0.00
52-wk high
€1.30
52-wk low
€0.69
No. of employees
10
News stories
From web sources and news partners
About Cocrystal Pharma Inc
CEO-
Employees10
Founded2006
HeadquartersBothell, Washington, United States
SectorPharmaceutical industry
Websitecocrystalpharma.com
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
-
-
225.00K
105.00K
Cost of goods sold
954.00K
1.62M
1.37M
2.14M
Cost of revenue
954.00K
1.62M
1.37M
2.14M
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
1.14M
862.00K
1.21M
1.15M
Operating expense
1.14M
862.00K
1.21M
1.15M
Total operating expenses
2.09M
2.48M
2.58M
3.29M
Operating income
-2.09M
-2.48M
-2.36M
-3.18M
Other non operating income
-
-
-
-
EBT including unusual items
-2.05M
-2.43M
-2.30M
-3.16M
EBT excluding unusual items
-2.05M
-2.43M
-2.30M
-3.16M
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-2.05M
-2.43M
-2.30M
-3.16M
Net profit margin
-
-
-1,021.78%
-3,013.33%
Earnings per share
-0.19
-0.17
-0.17
-0.23
Interest and investment income
22.00K
47.00K
22.00K
10.00K
Interest expense
-
-
-
-
Net interest expenses
22.00K
47.00K
22.00K
10.00K
Depreciation and amortization charges
-
-
-
-
EBITDA
-2.08M
-2.47M
-2.34M
-3.17M
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google apps